Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$570K Buy
2,707
+140
+5% +$30K 0.01% 276
2026
Q1
$568K Sell
2,567
-219
-8% -$53.6K 0.01% 264
2025
Q4
$706K Hold
2,786
0.01% 250
2025
Q3
$689K Hold
2,786
0.01% 254
2025
Q2
$669K Hold
2,786
0.01% 254
2025
Q1
$631K Hold
2,786
0.01% 254
2024
Q4
$573K Hold
2,786
0.01% 266
2024
Q3
$676K Hold
2,786
0.01% 257
2024
Q2
$596K Buy
2,786
+197
+8% +$42.8K 0.01% 264
2024
Q1
$582K Hold
2,589
0.01% 273
2023
Q4
$569K Sell
2,589
-10
-0.4% -$2.12K 0.01% 268
2023
Q3
$570K Sell
2,599
-279
-10% -$63.1K 0.01% 265
2023
Q2
$647K Buy
2,878
+289
+11% +$57.8K 0.01% 262
2023
Q1
$495K Hold
2,589
0.01% 279
2022
Q4
$478K Sell
2,589
-1,423
-35% -$250K 0.01% 285
2022
Q3
$667K Hold
4,012
0.01% 252
2022
Q2
$827K Hold
4,012
0.02% 246
2022
Q1
$970K Hold
4,012
0.02% 233
2021
Q4
$977K Hold
4,012
0.01% 234
2021
Q3
$820K Hold
4,012
0.01% 243
2021
Q2
$828K Buy
4,012
+2,294
+134% +$462K 0.01% 241
2021
Q1
$327K Hold
1,718
0.01% 333
2020
Q4
$326K Buy
+1,718
New +$321K 0.01% 325

Other funds holding STE

Welch & Forbes's STE Position: Q2 2026 in Review

Welch & Forbes increased its Steris (STE) stake by 5.5% in Q2 2026, buying an estimated $30K and bringing the position to 2,707 shares worth $570K. The position accounts for 0.01% of the portfolio, ranked #276.

Welch & Forbes first reported a position in STE in Q4 2020 and has held it in 23 quarters since. The position peaked at $977K in Q4 2021. 830 funds tracked by Wall St. Rank hold STE as of Q2 2026.

  • Welch & Forbes held 2,707 shares of Steris worth $570K as of Q2 2026.
  • Welch & Forbes bought 140 Steris shares in Q2 2026, an estimated $30K.
  • Steris made up 0.01% of Welch & Forbes's portfolio in Q2 2026, its #276 holding.
  • Welch & Forbes first reported a position in Steris in Q4 2020 and has held it in 23 quarters since.
  • Welch & Forbes's Steris position peaked at $977K in Q4 2021.
  • 830 funds tracked by Wall St. Rank held Steris as of Q2 2026.

Based on Welch & Forbes's 13F filing for Q2 2026, filed 30 Jul 2026.